Patents by Inventor Jeffrey Tokar

Jeffrey Tokar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biomarkers for the Diagnosis and Treatment of Pancreatic Cancer
    Publication number: 20140103204
    Abstract: Compositions and methods which indicate an increased risk for pancreatic carcinoma are disclosed.
    Type: Application
    Filed: December 17, 2013
    Publication date: April 17, 2014
    Applicant: The Institute for Cancer Research doing business as the Research Institute of Fox Chase Cancer Cent
    Inventors: Anthony T. Yeung, Jeffrey Tokar
  • Biomarkers for the diagnosis and treatment of pancreatic cancer
    Patent number: 8609437
    Abstract: Compositions and methods for use in methods and kits for the detection of an increased risk of pancreatic cancer are provided. Cyst fluid samples isolated from patients that are positive for at least three of the following markers, mucin 1, mucin 2, mucin 5AC, mucin 5B, mucin 6, CEA CAM 1, CEACAM 5, CEACAM 6, CEACAM 7, CEACAM 8, S100-A6, S100-A8, S100-A9 and S100-A11 indicate that such patients are at greater risk for the development of pancreatic cancer when compared to cyst fluid samples isolated from patients lacking these markers.
    Type: Grant
    Filed: January 21, 2009
    Date of Patent: December 17, 2013
    Assignee: The Institue for Cancer Research
    Inventors: Anthony T. Yeung, Jeffrey Tokar
  • Biomarkers for the Diagnosis and Treatment of Pancreatic Cancer
    Publication number: 20110008914
    Abstract: Compositions and methods which indicate an increased risk for pancreatic carcinoma are disclosed.
    Type: Application
    Filed: January 21, 2009
    Publication date: January 13, 2011
    Inventors: Anthony T. Yeung, Jeffrey Tokar